News mentioning Cobenfy
19 stories
Sep 2, 26Stripped of AstraZeneca safety net, BMS could face ‘carnage’ if high-risk clinical trial fails
Aug 14, 26MapLight dims preclinical programs to make phase 3-ready schizophrenia drug shine brighter
Jul 31, 26Sanofi to ‘rebuild trust’ with Regeneron; Apnimed adds to string of ‘upsized’ biotech IPOs